Marketing Authorisation Holder
Sites are permitted to use any brand/generic of Budesonide.
Dosing regime
1mg every 12 hours, for a total of 7 days.
Inhaled budesonide will be continued for 7-days in total, even in patients discharged from critical care unit before completing the 7-day therapy. The total duration of therapy will be assessed by looking at the drug chart administration records, and documenting in the CRF.
Dose changes
No dose changes for the inhaled prescriptions will be implemented.
Date entered TRAITS
July 2023